AN2 Therapeutics (ANTX) Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis and Malaria Oct 17, 2024 07:03AM
AN2 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business and Scientific Highlights Nov 9, 2023 04:05PM
AN2 Therapeutics (ANTX) Signs Grant Agreement to Discover Novel, Boron Based Therapies for Tuberculosis and Malaria Sep 26, 2023 07:02AM